Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey

Showing results (601-610 of 651) with videos related to

Pageof 66
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 18, 2012
Optimization of an ether series of mGlu5 positive allosteric modulators: molecular determinants of MPEP-site interaction crossoverJason T Manka, Paige N Vinson, Karen J Gregory, et al.
ACS Chemical Neuroscience|August 28, 2024
Discovery of VU6007496: Challenges in the Development of an M<sub>1</sub> Positive Allosteric Modulator Backup CandidateJulie L Engers, Katrina A Bollinger, Rory A Capstick, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2017
Challenges in the development of an M<sub>4</sub> PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amidesJames C Tarr, Michael R Wood, Meredith J Noetzel, et al.
ACS Chemical Neuroscience|March 25, 2025
Application of Deuterium in an M<sub>1</sub> Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422Julie L Engers, Jinming Li, Changho Han, et al.
BMC Genomics|January 29, 2011
Model SNP development for complex genomes based on hexaploid oat using high-throughput 454 sequencing technologyRebekah E Oliver, Gerard R Lazo, Joseph D Lutz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 10, 2008
Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in ratsCarrie K Jones, Ashley E Brady, Albert A Davis, et al.
Molecular Pharmacology|October 7, 2010
Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activityAlice L Rodriguez, Mark D Grier, Carrie K Jones, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2009
A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learningJana K Shirey, Ashley E Brady, Paulianda J Jones, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 21, 2014
Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100Nellie E Byun, Michael Grannan, Michael Bubser, et al.
ACS Chemical Neuroscience|February 5, 2025
Further Optimization of the mGlu<sub>1</sub> PAM VU6024578/BI02982816: Discovery and Characterization of VU6033685Carson W Reed, Jacob F Kalbfleisch, Jeremy A Turkett, et al.
Pageof 66

Showing results (601-610 of 651) with videos related to

Sort By:
Pageof 66
Bioorganic & Medicinal Chemistry Letters|September 18, 2012
Optimization of an ether series of mGlu5 positive allosteric modulators: molecular determinants of MPEP-site interaction crossoverJason T Manka, Paige N Vinson, Karen J Gregory, et al.
ACS Chemical Neuroscience|August 28, 2024
Discovery of VU6007496: Challenges in the Development of an M<sub>1</sub> Positive Allosteric Modulator Backup CandidateJulie L Engers, Katrina A Bollinger, Rory A Capstick, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2017
Challenges in the development of an M<sub>4</sub> PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amidesJames C Tarr, Michael R Wood, Meredith J Noetzel, et al.
ACS Chemical Neuroscience|March 25, 2025
Application of Deuterium in an M<sub>1</sub> Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422Julie L Engers, Jinming Li, Changho Han, et al.
BMC Genomics|January 29, 2011
Model SNP development for complex genomes based on hexaploid oat using high-throughput 454 sequencing technologyRebekah E Oliver, Gerard R Lazo, Joseph D Lutz, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 10, 2008
Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in ratsCarrie K Jones, Ashley E Brady, Albert A Davis, et al.
Molecular Pharmacology|October 7, 2010
Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activityAlice L Rodriguez, Mark D Grier, Carrie K Jones, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2009
A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learningJana K Shirey, Ashley E Brady, Paulianda J Jones, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 21, 2014
Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100Nellie E Byun, Michael Grannan, Michael Bubser, et al.
ACS Chemical Neuroscience|February 5, 2025
Further Optimization of the mGlu<sub>1</sub> PAM VU6024578/BI02982816: Discovery and Characterization of VU6033685Carson W Reed, Jacob F Kalbfleisch, Jeremy A Turkett, et al.
Pageof 66